Combining pH and metabolic activity imaging for response assessment in immune therapy
A computerized system for monitoring cancer therapy and a related method. The system comprises an input port (IN) for receiving two or more input images acquired of a subject, the two or more input images capable of recording metabolic activity and extracellular pH level. An evaluator (EVAL) of the system is configured to assess, based on the input images, i) a change over time in metabolic activity and ii) a change over time in extracellular pH level. The evaluator (EVAL) is further configured to establish, based on the assessment, an indication on whether or not there is a response to a cancer therapy in relation to a lesion of the subject or on whether the assessment is inconclusive. The indication is output through an output interface (OUT).
1. A computerized system for monitoring cancer therapy, comprising:
an input port for receiving two or more input images acquired of a subject, a first input image of the two or more input images recording metabolic activity based on a PET image and a second input image of the two or more input images recording extracellular pH level based on an MR image;
a computer configured to:
segment the two or more input images to find a lesion in the two or more input images;
assess i) a change (ma) in metabolic activity and ii) a change (pH) in extracellular pH level in the segmented two or more images by converting image values in the two or more input images to standard uptake values (SUVs):
form, from the SUVs, at least one ratio of pH/ma or ma/pH; and
c in relation to the lesion or on whether the assessment is inconclusive; and
an output interface for outputting said indication.
2. The system of claim 1 , wherein the computer is configured to establish in the indication that there is response to the cancer therapy if i) there is an increase in metabolic activity and there is increase in extracellular pH level or ii) there is a decrease in metabolic activity and increase in extracellular pH level.
3. The system of claim 1 , wherein the computer is configured to establish in the indication whether the response is a pseudo-progression or a real progression.
4. The system of claim 1 , wherein the computer includes an image segmenter to segment the two or more images for a region of interest (ROI), wherein the assessment of the changes of the metabolic activity and the extracellular pH level is based on image values in said ROI.
5. The system of claim 1 , wherein the assessment of the changes of the metabolic activity and the extracellular pH level is based on image values in a border portion of the ROI.
6. A non-transitory computer readable medium storing instructions executable by at least one processor to perform a computer-implemented method to monitor cancer therapy, the method comprising:
receiving two or more input images acquired of a subject, a first input image of the two or more input images recording metabolic activity based on a PET image and a second input image of the two or more input images recording extracellular pH level based on an MR image;
segmenting the two or more input images to find a lesion in the two or more input images;
assessing i) a change (ma) in metabolic activity and ii) a change (pH) in extracellular pH level in the segmented two or more images by converting image values in the two or more input images to standard uptake values (SUVs):
forming, from the SUVs, at least one ratio of pH/ma or ma/pH; and
establishing, based on the at least one ratio of pH/ma or ma/pH, an indication on whether or not there is a response to a cancer therapy in relation to the lesion or on whether the assessment is inconclusive; and
outputting said indication.
7. The non-transitory computer readable medium as per claim 6 , wherein the establishing includes establishing in the indication that there is response to the cancer therapy, if i) there is an increase in metabolic activity and there is increase in extracellular pH level or ii) there is a decrease in metabolic activity and an increase in extracellular pH level.
8. The non-transitory computer readable medium as per claim 6 , wherein the established indication is capable of distinguishing between a pseudo-progression and a real progression.
9. The non-transitory computer readable medium as per claim 6 wherein the establishing includes applying machine learning to the images.
10. A system for monitoring cancer therapy, comprising:
a positron emission tomography (PET) imager configured to acquire a PET image of a subject recording metabolic activity;
a magnetic resonance imaging (MRI) imager configured to acquire an MRI image of the subject recording extracellular pH level; and
a computer configured to:
assess a change (ma) over time in metabolic activity using the PET image and a change (pH) over time in extracellular pH level using the MRI image;
establish, based on the assessment, an indication on whether or not there is a response to a cancer therapy in relation to a lesion of the subject or on whether the assessment is inconclusive based on computing at least one ratio of pH/ma or ma/pH; and
output said indication.